Primary analysis from OAK, a randomized phase III study...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Primary analysis from OAK, a randomized phase III study comparing atezolizumab with docetaxel in 2L/3L NSCLC

Barlesi, F., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S., Hida, T., Kowalski, D., Dols, M.C., Cortinovis, D., Leach, J., Polikoff, J., Gandara, D., Barrios, C.H., Chen, D.S., He, P., Kowanetz
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw435.43
Date:
October, 2016
File:
PDF, 43 KB
english, 2016
Conversion to is in progress
Conversion to is failed